Holocene Advisors’s Biogen BIIB Stock Holding History

Holocene Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-132,500	Closed	-$45.9M	–	811
2021 Q2	$45.9M	Buy	+132,500	New	+$40.1M	0.26%	124

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Holocene Advisors's BIIB Position: Q2 2026 in Review

Holocene Advisors held its Biogen (BIIB) position steady in Q2 2026 at 4,793 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #675.

Holocene Advisors first reported a position in BIIB in Q1 2018 and has held it in 9 quarters since. The position peaked at $74.2M in Q4 2019. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Holocene Advisors held 4,793 shares of Biogen worth $1.04M as of Q2 2026.
Holocene Advisors left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Holocene Advisors's portfolio in Q2 2026, its #675 holding.
Holocene Advisors first reported a position in Biogen in Q1 2018 and has held it in 9 quarters since.
Holocene Advisors's Biogen position peaked at $74.2M in Q4 2019.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.